Pfizer has sued Aurobindo Pharma in connection with its filing of abbreviated new drug application (ANDA) for marketing generic version of Lipitor, Atorvastatin in the US market.
The lawsuit was filed to stop the Indian firm to manufacture and market the drug prior the expiration of its patent date i.e 8 January 2017.
The suit was filed in the US District Court of Delaware on 17 May.